Precipio

PRPO

Medical - Diagnostics & Research · Healthcare

Price

$24.64

+0.96 (+4.05%)

Market Cap

$44.0M

Exchange

NASDAQ

Winston Score

Winston is serious

Below-average fundamentals — multiple weak pillars.

Share count rising — dilution

+52.2% over 4y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 1.1M (2021) → 1.6M (2025)

Precipio is a small healthcare company that runs a cancer diagnostics laboratory. It tests patient tissue and blood samples to help doctors figure out what type of cancer a patient has, so the right treatment can be chosen. The company serves hospitals, oncology clinics, and physician groups, mainly across the United States.

Precipio earns money by charging for each diagnostic test it performs, with payments coming from insurance companies, hospitals, and sometimes patients directly. It also sells a product called IV-Cell, a technology that improves how certain cancer cells are grown and analyzed in labs. The company is very small, with a market cap under $10 million, and it operates at a loss, meaning it spends more than it earns right now. The biggest risk it faces is running out of cash before it can grow its test volume enough to become profitable.

Winston Score History

Growth Profile

For growth stock investors

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+48.0% YoY

YoY Growth Rate

Revenue accelerating

EPS Growth

-37.3% YoY

YoY Growth Rate

Earnings declining

R&D Spend

$0/ year

↓ Declining (-100% vs prior year)

0.0% of revenue

Below sector average (18%)

R&D spend declining — could signal cost-cutting or efficiency

Insider Activity

21.4%ownership

↑ Rising

Insiders increasing their stake — aligned with shareholders

Cash Position

Cash flow positive

$3M cash & investments

Quarterly Free Cash Flow

↑ Burn rate improving

Company generates more cash than it spends — no dilution risk from fundraising

Revenue accelerating

Precipio grew revenue 48% year-over-year and the growth rate is speeding up. That's the kind of momentum growth investors look for — the question is whether margins can follow.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin

43.2%

Healthy — 43.2% gross margin

Operating Margin

-22.7%

Losing money on operations — -22.7%

ROCE

-8.1%

Weak — -8.1% return on capital

Negative ROIC means the business is losing money on every dollar invested in it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY

+34.8%

Fast-growing sales (34.8% YoY)

EPS YoY

N/A

Data not available

EPS Consistency

4/8 quarters

Earnings inconsistent quarter-to-quarter

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion

N/A

Data not available

FCF Margin

2.1%

Thin free cash flow (2.1%)

FCF margin between 0% and 10%. Some cash from sales, but not a lot.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity

0.24

Conservative — low debt load (0.24)

Interest Cover

N/A

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)

N/M

Negative earnings — P/E not meaningful

P/E vs Forward

N/A

not available

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.

🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.

Start free trial